221 Crescent Street, 5th Floor
Waltham,  MA  02453

United States


At LumiraDx, we make healthcare simpler and more accessible with smarter connected diagnostics. LumiraDx was founded in 2014 by a group of entrepreneurs who have a successful track record in building and scaling diagnostics businesses over three decades. LumiraDx develops, manufactures and commercializes an innovative point of care diagnostic Platform. The LumiraDx Platform is designed to deliver lab comparable diagnostic results at the point of care in minutes. It is designed to be affordable and accessible for healthcare providers globally, and to strengthen community-based healthcare.

 Corporate, Product or Service Images


  • LumiraDx Platform
    The LumiraDx Platform is an innovative, next generation POC diagnostic system combining a small, portable Instrument, advanced low-cost Test Strip and seamless digital connectivity. LumiraDx recently launched the SARS-CoV-2 Antigen Test for use on the LumiraDx Platform delivering results in 12 minutes with 97.6% PPA to an EUA approved RT-PCR method within the first 12 days of symptom onset....

  • LumiraDx high sensitivity point of care Platform

    The LumiraDx Platform and tests are designed on the same principles as lab analyzer systems, to deliver accurate results compared to laboratory reference assays, in a portable, easy to use point of care solution.

    LumiraDx SARS-CoV-2 Antigen Test

    The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens from patients suspected of COVID-19.

    The Test, which has received Emergency Use Authorization from the FDA will help meet the global challenge of delivering fast and cost-efficient COVID-19 tests in community care settings.

    LumiraDx Connect

    For integrated connectivity, LumiraDx Connect ensures the easy, secure transfer of results from the LumiraDx Instrument to Connect Manager or to a patient’s electronic health record.